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Background: Glycol ethers are present in a wide range of occupational and domestic products. 
Animal studies have suggested that some of them may affect ovarian function.
oBjective: We examined the relation between women’s exposure to glycol ethers and time 
to pregnancy.
Methods: We used chromatography coupled to mass spectrometry to measure eight glycol ether 
metabolites in urine samples from randomly selected women in the PELAGIE mother–child cohort 
who had samples collected before 19 weeks of gestation. Using time to pregnancy information 
collected at the beginning of the pregnancy (women were asked how many months it took for 
them to conceive), we estimated associations between metabolite levels and time to pregnancy in 
519 women with complete data using discrete-time Cox proportional hazards models to adjust for 
potential confounders. 
results: We detected glycol ether metabolites in 6% (for ethoxyacetic acid) to 93% (for phenoxy-
acetic and butoxyacetic acids) of urine samples. Phenoxyacetic acid was the only metabolite with 
a statistically significant association with longer time to pregnancy [fecundability OR = 0.82; 
95% CI: 0.63, 1.06 for the second and third quartile combined; fecundability OR = 0.70; 95% CI: 
0.52, 0.95 for a fourth-quartile (≥ 1.38 mg/L) vs. first-quartile concentration (< 0.14 mg/L)]. This 
association remained stable after multiple sensitivity analyses.
conclusion: Phenoxyacetic acid, which was present in most of the urine samples tested in our 
study, was associated with increased time to pregnancy. This metabolite and its main parent com-
pound, 2-phenoxyethanol, are plausible causes of decreased fecundability, but they may also be 
surro gates for potential coexposures to compounds frequently present in cosmetics. 
citation: Garlantézec R, Warembourg C, Monfort C, Labat L, Pulkkinen J, Bonvallot N, 
Multigner L, Chevrier C, Cordier S. 2013. Urinary glycol ether metabolites in women and time 
to pregnancy: the PELAGIE cohort. Environ Health Perspect 121:1167–1173; http://dx.doi.
org/10.1289/ehp.1206103
Introduction
Organic solvents are present in a wide  variety 
of occupational and domestic products, 
including cleaning agents, cosmetics (i.e., 
makeup, creams, soaps, and deodorants), 
paints, and varnishes. Several previous studies 
have reported associations between women’s 
occupational exposure to solvents and fertility 
impairment, although the results were not all 
concordant (Mendola et al. 2008). Limitations 
of such studies have included the lack of objec-
tive assessment of exposure to specific solvents 
and a failure to study non occupational expo-
sure. Biological monitoring of chemicals is a 
useful alternative because it provides an inte-
grative and objective exposure measurement 
(Angerer et al. 2007; Calafat et al. 2006).
From the solvents suspected of impair-
ing female fertility, we decided to focus on 
glycol ethers (GEs), a family of oxygenated 
solvents that includes > 30 different ethers 
of ethylene glycol and propylene glycol. GEs 
represented 5% of the total volume of sol-
vents used in France in 2004 (Triollet 2005). 
Chemical analyti cal methods were available 
to measure eight metabolites of the GEs most 
frequently used in France at the time of the 
study [Agence française de sécurité sanitaire 
de l’environnement et du travail (AFSSET) 
2008] (Table 1). Animal studies have 
reported that several GEs may affect ovar-
ian function: 2-methoxyethanol (EGME), 
2-ethoxyethanol (EGEE), 2-butoxyethanol 
(EGBE), 2-phenoxy ethanol (EGPhE), and 
1,2-bis(methoxy ethoxy)ethane (TEGDME) 
(reviewed by Multigner et al. 2005). In occu-
pational epidemiologic studies in women con-
ducted in the semi conductor industry, where 
EGME and EGEE were the main GEs used, 
GE exposure was associated with prolonged 
time to pregnancy (TTP) (Chen et al. 2002; 
Correa et al. 1996; Eskenazi et al. 1995; Gray 
et al. 1996) and with prolonged menstrual 
cycles (Hsieh et al. 2005). However, use of 
EGME and EGEE has been restricted in 
France since 1999 (AFSSET 2008). Neither 
EGBE nor EGPhE—both frequently pres-
ent in consumer products and suspected of 
impairing women’s fertility—has ever been 
studied in women.
The objective of our work was to study 
the relation between both non occupational 
and occupational exposure to GEs in 
women and TTP.
Materials and Methods
S t u d y  p o p u l a t i o n .  T h e  P E L A G I E 
(Per turbateur s  endocr in iens :  Étude 
Longitudinale sur les Anomalies de la 
Grossesse, l’Infertilité et l’Enfance) cohort 
study, described elsewhere (Garlantézec et al. 
2009), included 3,421 pregnant women 
in three districts of Brittany (northwestern 
France) between 2002 and 2006. Women 
were recruited by their gynecologists, obstetri-
cians, or ultrasonographers at visits for 
prenatal care before 19 weeks of gestation and 
were followed through the end of pregnancy. 
Participants provided informed consent for 
partici pation, and the INSERM (Institut 
national de la santé et de la recherche 
médicale) ethics committee approved the 
study procedures.
At inclusion, women completed a self-
administered questionnaire that covered fam-
ily social and demographic characteristics, 
diet, and lifestyle. Each woman returned the 
question naire by mail to our laboratory along 
with a urine sample (first morning void) in a 
10-mL test tube (95 × 16-mm polypropylene, 
with wing plug). Upon arrival at the labo-
ratory, urine samples were frozen at –20°C 
until analysis.
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Because of costs, the biomonitoring 
study included only a randomly selected 
sample (n = 609) of the women in the 
PELAGIE study.
Assessment of TTP. TTP was based on the 
answer to the question “How long did it take 
you to become pregnant?” (in months) from 
the self-administered question naire collected 
at inclusion. The question naire also asked 
about contraceptive use, voluntary interrup-
tion of contraceptive use (to assess whether the 
pregnancy was planned), fertility medication 
(to censor at time of conception), and repro-
ductive history (to validate the self-reported 
TTP by verifying the absence of any interim 
miscarriage during the TTP). Among women 
with urine analyses, TTP was available for 
519 (85%) (Figure 1). TTP was unavailable 
when the pregnancy was unplanned (n = 39), 
if it was not clear whether the pregnancy was 
planned or not (n = 45), or if TTP data were 
missing (n = 6).
Chemical analysis of GE metabolites. 
Chemical analyses were performed at the 
Toxicology and Genopathy Laboratory 
at CHRU (Centre Hospitalier Régional 
Universitaire) Lille following the method 
of Labat et al. (2008). GE metabolites were 
measured by gas chromatography coupled 
to mass spectrometry, and detection was 
performed in negative ioniza tion mode with 
methane in full-scan acquisition between 
85 and 152 m/z. This method allowed for 
the simultaneous analysis of eight alkoxy-
carboxylic acids, the main metabolites of the 
GEs in use in Europe at the time of urine 
collection (Table 1): methoxy acetic acid 
(MAA), methoxy ethoxy acetic acid (MEAA), 
ethoxy acetic acid (EAA), ethoxy ethoxy acetic 
acid (EEAA), 2-butoxy acetic acid (BAA), 
n-propoxy acetic acid (PAA), phenoxy acetic 
acid (PhAA), and 2-methoxy propionic acid 
(2-MPA). This method yields coefficients of 
variation < 10% at 0.10 mg/L (Labat et al. 
2008). The method is linear (r² = 0.99) 
from 0.05 to 2.0 mg/L for all of the alkoxy-
carboxylic acids, with a limit of detection 
(LOD) of 0.05 mg/L.
The influence of sampling conditions, 
including transportation time at room tem-
perature, duration of storage at –20°C, and 
type of acidic stabilizer [hydrochloric acid 
(HCl) or nitric acid (HNO3)] on urinary 
measurements, and of individual parameters 
(urinary creati nine level and gestational age at 
inclusion) was reported previously (Cordier 
et al. 2012). In that study, the BAA detec-
tion rate decreased with the number of days 
at ambient temperature when HCl was used 
as a stabilizer, but not when HNO3 was used; 
therefore, here we present results for BAA only 
for the subset of 412 women whose samples 
were stabilized with HNO3. Statistical analy sis 
performed by Cordier et al. (2012) showed 
that creatinine level was associated with MAA, 
MEAA, EEAA, BAA, and PhAA, and that 
transportation time appeared to influence the 
levels of BAA and the detection of 2-MPA. 
Duration of storage [median: 1,090 days; 
quartile (Q) 1, 858 days; Q3, 1,377 days] was 
associated with levels of MEAA, EEAA, PAA, 
and 2-MPA (Cordier et al. 2012). Thus, we 
considered these covariates (creatinine level, 
gestational age at inclusion, transport dura-
tion, and duration of storage between collec-
tion and analysis) to be potential confounders. 
Statistical analysis. Each metabolite with 
a detection rate < 50% was categorized in two 
classes (< LOD and ≥ LOD). Other metabo-
lites were categorized in three classes (< 25th 
percentile, 25th–74th percentile, ≥ 75th 
percentile) and were also modeled as ordinal 
variables coded using integer values (0, 1, 2) 
to perform trend tests. Each metabolite with 
a detection rate > 30% was also treated as 
continuous with a distribution-based mul-
tiple imputation method for handling values 
< LOD (Jin et al. 2011; Lubin et al. 2004). 
Assuming a lognormal distribution of each 
metabolite, this method uses maximum likeli-
hood estimates to estimate distribution param-
eters (Jin et al. 2011; Lubin et al. 2004). We 
used the Cox proportional hazards models 
adapted for discrete-time data to estimate 
fecundability odds ratios (fORs) associated 
with urinary biomarkers of exposure to GE 
metabolites. The fOR estimates the odds of 
achieving pregnancy in any given month, con-
ditional on not having become pregnant in a 
previous cycle. An fOR of < 1 indicates longer 
TTP and decreased fecundability. When TTP 
was > 12 months (13% of women, n = 66), 
the value was censored at 12 months. When 
couples who sought medical assistance due 
to difficulty in becoming pregnant reported 
TTP < 12 months (3% of women, n = 16), we 
censored at their self-reported TTP, consider-
ing it as a minimal one (as if they had not used 
medical assistance). 
Covariates systematically included in the 
models were well-established infertility risk 
factors that were self-reported in our study: 
maternal age (years, continuous), body mass 
index (BMI; < 18.5 kg/m², 18.5–25 kg/ m², 
≥ 25 kg/m²), maternal smoking status when 
first attempting pregnancy (yes/no), and 
oral contraceptive use before attempting 
pregnancy (yes/no). We observed that the 
probability in our cohort of conceiving in 
Table 1. Primary products in France that contain 
GEs (2000–2006) and their main urinary metabolites. 
Products GEsa Metabolites
Cosmetics EGPhE PhAA
EGBE BAA
DEGBE BEAA, BAA
DEGEE EEAA, EAA
Drugs DEGEE EEAA, EAA
EGPhE PhAA
Cleaning agents DEGEE EEAA, EAA
DEGBE BEAA, BAA
EGBE BAA
PGME 2‑MPAb
DEGME MEAA, MAA
TEGME MEAA, MAA
TEGDME MAA
Biocides PGME 2‑MPAb
EGBE BAA
DEGBE BEAA, BAA
DEGEE EEAA, EAA
EGPhE PhAA
Paints, varnishes, 
and inks
PGME 2‑MPAb
EGBE BAA
DEGBE BEAA, BAA
DEGEE EEAA, EAA
TEGEE EEAA, EAA
EGnPE PAA
Abbreviations: BAA, 2-butoxyacetic acid; DEGBE, 
2-(2-butoxy ethoxy)ethanol;  DEGEE, 2-(2-ethoxy-
ethoxy)ethanol; DEGME, 2-(2-methoxyethoxy)ethanol; 
EAA, ethoxy acetic acid; EEAA, ethoxyethoxy acetic 
acid; EGBE, 2-butoxy ethanol; EGEE, 2-ethoxy ethanol; 
EGME, 2-methoxy ethanol; EGnPE, 2-propoxy ethanol; 
EGPhE, 2-phenoxy ethanol; MAA, methoxy acetic acid; 
MEAA, methoxy ethoxy acetic acid; 2-MPA, 2-methoxy-
proprionic acid; PAA, n-propoxyacetic acid; PGME, 
methoxy propanol; PhAA, phenoxy acetic acid; TEGDME, 
1,2-bis(methoxyethoxy)ethane; TEGEE, 2-(2-(2-ethoxy-
ethoxy)ethoxy)ethanol; TEGME, 2-(2-(2-methoxy ethoxy)
ethoxy)ethanol. Data from AFSSET (2008).
aGEs are presented for products by most to least frequently 
used. bMetabolite derived from minor β isomer of PGME. Figure 1. Flow diagram showing study sample selection. 
PELAGIE cohort
(N = 3,421)
Subcohort, randomly selected
(n = 609)
Planned pregnancies
(n = 525)
Available TTP and chemical analysis
(n = 519)
39 Unplanned pregnancies
45 Missing data about whether 
pregnancy was planned
6 Missing TTP
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the first 2–3 months was higher for women 
who had not used oral contracep tion imme-
diately before attempting pregnancy than 
for women who did. After 3 months, these 
two groups no longer differed substantially. 
This finding, which has also been reported by 
others (Axmon et al. 2006), led us to stratify 
our analyses for oral contraceptive use with a 
stratified Cox model.
We also evaluated other potential covari-
ates: year of inclusion (2002, 2003, 2004, 
2005–2006), district of residence (Ille-et-
Vilaine, Côtes d’Armor, others), rural/urban 
residence area, season as a time-varying 
covariate, self-reported maternal education 
level (primary/secondary, baccalaureate, post-
baccalaureate), coffee consumption at inclu-
sion (no more than once a day, at least twice 
a day), fish consumption (less than monthly, 
1–4 times a month, at least twice a week), 
shellfish consumption (less than twice a 
month, 2–8 times a month, at least twice a 
week), paternal occupational exposure to sol-
vents at inclusion according to a job-exposure 
matrix (Ferrario et al. 1988) (unemployed, 
none, medium, high), and variables describ-
ing urine sampling conditions. These variables 
were to be included in the models if they 
modified the fOR by ≥ 10%, but none met 
this criterion. In addition, when we observed 
correlations between metabolites and between 
TTP and at least one of these metabolites, 
we ran models that simultaneously included 
these metabolites.
Correlations between the urinary metabo-
lites were analyzed with chi-square or Fisher’s 
exact tests, Tobit regression, or Spearman 
rank correlations, depending on the level of 
detection. Statistical significance was defined 
as p < 0.05.
Sensitivity analyses. The first set of sen-
sitivity analyses examined the consistency 
of our findings in light of potential validity 
issues for TTP studies. As recom mended by 
previous studies (Joffe et al. 2005; Weinberg 
et al. 1994), in addition to the main analyses, 
we report estimates from analyses a) restricted 
to the 237 primi parous women, b) exclud-
ing 113 women who reported conceiving in 
the first month, c) including 39 pregnancies 
resulting from contraceptive failure (TTP was 
assigned a value of 0), d) excluding 37 women 
seeking fertility treatment, and e) changing 
the censoring time from 12 months to 7, 10, 
or 15 months.
Results
The 519 eligible women in our study had 
a mean age of 29.4 years when they began 
attempting to conceive, and their educational 
attainment was high: Around 63% of partici-
pants had received some post baccalaureate 
education (Table 2). Mean gestational age at 
inclusion was 9.6 weeks (Q1, 7.7 weeks; Q3, 
Table 2. Median time to pregnancy and crude fOR (fecundability odds ratio) according to population 
characteristic.
Characteristic n (%)
Median TTP 
(Q1–Q3)a
Crude 
fOR (95% CI)a p‑Value
Total 519 (100.0) 3 (2–7)
Year of inclusion 0.48
2002 62 (12.0) 3 (1–6) Reference
2003 205 (39.5) 3 (2–7) 0.77 (0.55, 1.09)
2004 188 (36.2) 3 (1–6) 0.88 (0.62, 1.25)
2005–2006 64 (12.3) 3 (2–6) 0.88 (0.57, 1.33)
District of residence 0.84
Ille‑et‑Vilaine 348 (67.1) 3 (2–6.5) Reference
Côtes d’Armor 130 (25.0) 3 (2–6) 1.00 (0.78, 1.27)
Others 41 (7.9) 4 (2–7) 0.89 (0.60, 1.32)
Educational level 0.06
Primary/secondary 89 (17.2) 5 (2–6.5) Reference
Baccalaureate 103 (19.9) 3 (2–10) 0.95 (0.67, 1.34)
Postbaccalaureate 326 (62.9) 3 (2–6) 1.26 (0.94, 1.68)
Missing 1 9 —
Maternal age (year) at pregnancy attempt 0.21
< 25 61 (11.7) 3 (2–8) Reference
25–30 206 (39.7) 3 (2–7) 1.07 (0.75, 1.52)
30–35 195 (37.6) 3 (2–6) 1.34 (0.94, 1.92)
≥ 35 57 (11.0) 3 (2–7) 1.15 (0.74, 1.79)
Mean ± SD 29.4 ± 4.0
Prepregnancy BMI (kg/m²) 0.29
< 18.5 39 (7.6) 3 (1–5) 1.14 (0.75, 1.73)
18.5–25 399 (77.3) 3 (2–6) Reference
≥ 25 78 (15.1) 3 (2–8) 0.81 (0.60, 1.09)
Missing 3 6 (1–12) —
Mean ± SD 22.1 ± 3.4
Gestational age at inclusion (weeks) 0.25
< 10 219 (42.2) 3 (2–7) Reference
10–13 240 (46.2) 4 (2–7) 0.94 (0.75, 1.18)
> 13 60 (11.6) 3 (2–5) 1.27 (0.89, 1.81)
Mean ± SD 9.6 ± 2.5
Parity 0.02
0 237 (45.7) 3.5 (2–8) Reference
1 193 (37.2) 3 (2–6) 1.26 (1.00, 1.59)
≥ 2 89 (17.2) 3 (1–6) 1.48 (1.09, 1.99)
History of miscarriage 0.004
No 434 (83.6) 3 (2–6) Reference
Yes 85 (16.4) 4 (2 –10) 0.65 (0.49, 0.87)
Oral contraceptive use before pregnancy attempt 0.58
No 122 (23.5) 3 (1–7) Reference
Yes 396 (76.5) 3 (2–6) 1.07 (0.84, 1.38)
Missing 1 1 (1–1) —
Maternal smoking at pregnancy attempt 0.22
No 362 (70.8) 3 (2–6) Reference
Yes 149 (29.2) 3 (2–8) 0.86 (0.69, 1.09)
Missing 8 6 (4–8.5) —
Coffee consumption at inclusion 0.94
≤ Once per day 366 3 (2–7) Reference
At least twice per day 116 3 (2–6.5) 0.99 (0.78, 1.27)
Fish consumption 0.81
Less than monthly 102 (19.7) 3 (2–7) Reference
1–4 times per month 263 (50.9) 3 (2–7) 1.04 (0.79, 1.37)
At least twice per week 152 (29.4) 3 (2–6) 1.10 (0.81, 1.50)
Missing 2 3 (3–3) —
Shellfish consumption 0.36
Less than twice per month 353 (68.0) 3 (2–6) Reference
2–8 times per month 126 (24.3) 3 (2–7) 0.98 (0.76, 1.26)
At least twice per week 40 (7.7) 4 (2–8) 0.74 (0.50, 1.12)
Marital status 0.30
Live alone 5 (1.0) 3 (2–6) 0.57 (0.20, 1.64)
Lives with partner 513 (99.0) 5 (4–12) Reference
Missing 1 17 —
Fertility treatment
No 482 (92.9) —
Yes 37 (7.1) —
CI, confidence interval. 
aBased on data from women who did not seek medical assistance to achieve pregnancy (n = 482).
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13.3 weeks). More than half of the partici-
pants already had a child, and around 16% 
had previously miscarried. Most (75%) of the 
women had used oral contraceptives before 
trying to conceive, and around 7% had under-
gone fertility treatment. 
As we expected, the entire cohort and 
the random subcohort were similar for these 
characteristics (see Supplemental Material, 
Table S1). The median TTP was 3 months 
(Q1–Q3, 2–7 months) (Table 2). Increased 
parity and unemployment were statistically 
associated with a reduced TTP (fOR > 1.0), 
and a history of miscarriage was significantly 
associated with a longer TTP (fOR < 1.0).
As shown in Table 3, BAA and PhAA 
were detected in 93% of the women’s uri-
nary samples and MEAA in more than half. 
The highest median concentration (estimated 
from all detected values) was observed for 
PhAA (0.48 mg/L).
When we compared the likelihood of 
detection (i.e., concentration ≥ LOD versus 
< LOD) for metabolites that were detected 
in < 30% of samples (specifically, MAA, 
EAA, EEAA, PAA, and 2-MPA), only PAA 
detection and 2-MPA detection were signifi-
cantly correlated, although we did observe 
non significant associations between MAA 
and MPA (p = 0.08) and between EAA and 
EEAA (p = 0.09) (see Supplemental Material, 
Table S2). When we evaluated correlations 
between detection of the metabolites above 
and the concentration of GE metabolites 
detected in the majority of samples (MEAA, 
BAA, and PhAA), we found significant cor-
relations between MAA ≥ LOD and MEAA 
concentration, EEAA ≥ LOD and PhAA con-
centration, MPA ≥ LOD and the concentra-
tions of MEAA and BAA, and PAA ≥ LOD 
and BAA concentration (see Supplemental 
Material, Table S3). However, there were 
no correlations between MEAA, BAA, and 
PhAA concentrations (see Supplemental 
Material, Table S4).
Table 4 shows the associations between 
TTP and each GE urinary metabolite. 
Fecundability increased with PAA detection 
[fOR = 1.30; 95% confidence interval (CI): 
0.94, 1.80]. PhAA was the only metabolite sig-
nificantly associated with TTP: a Q4 concen-
tration of PhAA (≥ 1.38 mg/L) was associated 
with a 30% decrease (fOR = 0.70; 95% CI: 
0.52, 0.95) in the odds of becoming pregnant 
each month, compared with the Q1 concen-
tration (< 0.14 mg/L). Moreover, we observed 
a statistically significant dose–response trend in 
which fecundability decreased as PhAA levels 
increased (p-trend = 0.02). This result was con-
firmed by the analysis with PhAA levels treated 
as a continuous variable (fOR for a 1-mg/L 
increase in PhAA = 0.95; 95% CI: 0.90, 1.00). 
Because of the positive correlation between 
PhAA levels and EEAA detection, we further 
adjusted for EEAA, but the association with 
PhAA remained unchanged (fOR for a 1-mg/L 
increase in PhAA = 0.95; 95% CI: 0.90, 1.00).
The sensitivity analyses of subsets of 
women and the influence of different censor-
ing times for TTP (Figure 2) yielded simi-
lar conclusions for most of the metabolites. 
The association of longer TTP with a higher 
PhAA level remained stable. EEAA detection 
was significantly associated with a longer TTP 
among primiparous women.
Discussion
In our study population, concentrations of 
PhAA (the primary metabolite of EGPhE) in 
urine samples collected at 9.6 weeks of gesta-
tion (on average) were associated with longer 
TTP. This association remained stable after 
sensitivity analyses. The other GE urinary 
metabolites measured in our study were not 
associated with reduced fecundability.
This association of PhAA concentration 
with TTP may be a chance finding due to 
multiple comparisons, or it could be a result of 
Table 3. Distribution of GE metabolites (alkoxycarboxylic acids) in urine samples from 519 women. 
Alkoxycarboxylic acid 
(LOD = 0.05 mg/L)
Values ≥ LODa  
[n (%)]
Percentile (mg/L) Maximum 
(mg/L)
Median  
(values ≥ LOD) (mg/L)25th 50th 75th
MAA 146 (28) < LOD < LOD 0.06 2.97 0.09
MEAA 289 (56) < LOD 0.06 0.26 3.90 0.23
EAA 21 (4) < LOD < LOD < LOD 0.62 0.06
EEAA 92 (19) < LOD < LOD < LOD 30.00 0.09
PAA 61 (12) < LOD < LOD < LOD 0.24 0.07
BAAa 385 (93) 0.085 0.12 0.16 0.62 0.13
PhAA 484 (93) 0.14 0.38 1.38 36.00 0.48
2‑MPA 29 (6) < LOD < LOD < LOD 0.76 0.13
Abbreviations: BAA, butoxy acetic acid; EAA, ethoxyacetic acid; EEAA, ethoxyethoxyacetic acid; MAA, methoxyacetic 
acid; MEAA, methoxy ethoxy acetic acid; 2-MPA, 2-methoxyproprionic acid; PAA, n-propoxy acetic acid; PhAA, phenoxy-
acetic acid. 
aExcluding 107 samples that were stabilized with HCl. 
Table 4. Relation between GE metabolites (alkoxycarboxylic acids) in urine samples from 519 women 
and TTP. 
Metabolite level
Crude Adjusteda
n fOR (95% CI) p‑Trend n fOR (95% CI) p‑Trend
MAA
< LOD 373 Reference 365 Reference
≥ LOD 146 1.05 (0.84, 1.33) 142 1.10 (0.87, 1.39)
MEAA 0.31 0.29
< LOD 230 Reference 224 Reference
LOD to < 0.23 mg/L 144 1.22 (0.95, 1.56) 140 1.24 (0.96, 1.61)
≥ 0.23 mg/L 145 1.12 (0.87, 1.43) 143 1.12 (0.87, 1.45)
Continuousb 519 1.02 (0.78, 1.32) 507 1.03 (0.77, 1.37)
EAA
< LOD 498 Reference 486 Reference
≥ LOD 21 0.90 (0.52, 1.56) 21 0.94 (0.54, 1.63)
EEAA
< LOD 427 Reference 416 Reference
≥ LOD 92 0.88 (0.67, 1.16) 91 0.88 (0.66, 1.17)
PAA
< LOD 458 Reference 447 Reference
≥ LOD 61 1.25 (0.91, 1.72) 60 1.30 (0.94, 1.80)
BAA 0.96 0.86
Q1 (< 0.09) 103 Reference 101 Reference
Q2–Q3 (0.09 to < 0.16 mg/L) 192 0.98 (0.74, 1.31) 189 0.92 (0.68, 1.24)
Q4 (≥ 0.16 mg/L) 117 1.01 (0.73, 1.39) 112 0.96 (0.70, 1.34)
Continuousb 412 1.95 (0.39, 9.79) 402 1.44 (0.28, 7.55)
PhAA 0.02 0.02
Q1(< 0.14 mg/L) 128 Reference 126 Reference
Q2–Q3 (0.14 to < 1.38 mg/L) 261 0.81 (0.63, 1.05) 255 0.82 (0.63, 1.06)
Q4 (≥ 1.38 mg/L) 130 0.70 (0.52, 0.94) 126 0.70 (0.52, 0.95)
Continuousb 519 0.95 (0.90, 1.00)c 507 0.95 (0.90, 1.00)c 
2‑MPA
< LOD 490 Reference 478 Reference
≥ LOD 29 1.05 (0.66, 1.65)  29 1.10 (0.69, 1.75)  
Abbreviations: BAA, butoxy acetic acid; EAA, ethoxyacetic acid; EEAA, ethoxyethoxyacetic acid; MAA, methoxyacetic 
acid; MEAA, methoxy ethoxy acetic acid; 2-MPA, 2-methoxyproprionic acid; PAA, n-propoxy acetic acid; PhAA, phenoxy-
acetic acid. LOD = 0.05 mg/L. 
aAdjusted for maternal age at pregnancy attempt (years), prepregnancy BMI (< 18.5 kg/m², 18.5–25 kg/m², ≥ 25 kg/m²), mater-
nal smoking at pregnancy attempt (no/yes), and oral contraceptive use before pregnancy attempt (no/yes). bEstimated by 
multiple imputation for non detects. cFor 95% CIs, values of 1.00 were excluded before rounding to two decimal places. 
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uncontrolled confounding or other sources of 
bias. However, it has some biological plausi-
bility. The high detection rate of PhAA (93%) 
in our population is consistent with the fre-
quent use of EGPhE, its main precursor, in 
cosmetics. EGPhE is also present in pharma-
ceutical products (AFSSET 2008; INSERM 
2006) and biocides (AFSSET 2008), and 
PhAA is used as a food flavoring agent [Joint 
Food and Agriculture Organization of the 
United Nations/World Health Organization 
Expert Committee on Food Additives 
(JECFA) 2002]. However, these three sources 
are probably negligible compared with its cos-
metic uses [Agence nationale de sécurité du 
médicament et des produits de santé (ANSM) 
2012]. According to French surveys (AFSSET 
2008; INSERM 2006), at the time of our 
study EGPhE was present in at least 50% of 
perfumes, creams, lotions, makeup, and hair 
products (except dyes), for example, but it was 
present in only 15 specific individual pharma-
ceuti cal products (of all drugs authorized 
for sale in France) and in < 1% of biocides 
(AFSSET 2008; INSERM 2006). Moreover, a 
study by the French drug and cosmetic safety 
agency (ANSM 2012) estimated that EGPhE 
intake in cosmetics reached 2 mg/kg/day with 
daily use of non rinsed cosmetics (i.e., creams, 
lotions, powders, perfumes, lipsticks, nail pol-
ish, and eye and facial makeup) compared 
with 0.3 mg/kg/day among drug users and 
0.004 mg/kg/day from food (AFSSET 2008; 
JECFA 2002). EGPhE has been reported in 
some cleaning products in the United States 
(Scognamiglio et al. 2012), but this does not 
seem to be the case in France (AFSSET 2008).
An expert  rev iew from INSERM 
(Multigner et al. 2005) stated that EGPhE 
was one of five GEs (EGME, EGEE, EGBE, 
and TEGDME) likely to impair ovarian func-
tion (INSERM 1999, 2006). The evalua tion 
of EGPhE was based on a single study in 
mice, which reported a decreased number 
of live pups in the exposed group (Heindel 
et al. 1990). Our results are consistent with 
the INSERM evaluation for EGPhE, but 
they do not suggest that the other tested GEs 
(EGME, EGEE, EGBE, and TEGDME) 
have an impact on female fecundability at 
the levels observed in our study. We have no 
explanation for the non significant decrease in 
TTP in association with PAA ≥ LOD in urine 
samples collected during pregnancy other 
than chance or uncontrolled bias. To our 
knowledge, this GE has never been studied in 
relation to fertility in animal studies.
The only epidemiological studies that have 
previously evaluated the association between 
GE exposure and female fertility were per-
formed in the semi conductor industry (Chen 
et al. 2002; Correa et al. 1996; Eskenazi et al. 
1995; Gray et al. 1996), where the prin-
cipal GEs used were EGME, EGEE, and 
1,2-dimethoxyethane. In that occupational 
setting, prolonged TTP was associated with 
exposure to these GEs, which was estimated 
using indirect methods (job title, tasks, and 
expert assessment). However estimates from 
those studies may be biased due to expo-
sure misclassifi ca tion or frequent coexposure 
to other potential repro toxic chemicals (i.e., 
arsenic, isopropyl alcohol, hydrofluoric acid, 
phosphorous compounds, and xylene) in this 
occupational setting (Cordier and Multigner 
2005). In the present study, MAA and EAA 
(the main metabolites of the three GEs com-
monly used in the semi conductor industry) 
were not frequently detected and were not 
associated with TTP. However, the regulation 
of these GEs in Europe since 1999 and the 
absence from our study of any women working 
in the semi conductor industry, where expo-
sure to these GEs is high (mean at the end 
Figure 2. Adjusted fORs and 95% CIs for association of medium and high levels of alkoxycarboxylic acids 
with TTP compared with the lowest levels, according to various sensitivity analyses: a) main population; 
b) limited to 237 primiparous women; c) excluding 113 women who conceived in the first month of trying; 
d)  including 39 pregnancies resulting from contraceptive failure (TTP = 0); e) excluding 37 women who 
used fertility treatment; f) censored at 7 months; g) censored at 10 months; and h) censored at 15 months. 
For metabolites analyzed in three classes (MEAA, BAA, PhAA), medium and high levels are shown in 
Table 4; for metabolites analyzed in two classes (MAA, EAA, EEAA, PAA, and 2-MPA), high levels are 
≥ LOD. Abbreviations: BAA, butoxy acetic acid; EAA, ethoxy acetic acid; EEAA, ethoxy ethoxy acetic acid; 
MAA, methoxy acetic acid; MEAA, methoxy ethoxy acetic acid; 2-MPA, 2-methoxy proprionic acid; PAA, 
n-propoxy acetic acid; PhAA, phenoxy acetic acid. 
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of the workday in France: MAA, 39.2 mg/L; 
EAA, 14.2 mg/L) (AFSSET 2008), may 
explain the low presence of their metabolites in 
our study population and the lack of associa-
tions with TTP.
Measurement of urinary alkoxycarboxylic 
acids is the method of choice for monitor-
ing occupational exposure to GEs (Laitinen 
and Pulkkinen 2005; Lauwerys et al. 2007); 
because this method has the capacity to mea-
sure exposure from all sources, it could be 
used to monitor the general population. The 
metabolites measured in our study have half-
lives ranging from 6 to 80 hr and therefore 
represent recent exposures only. However, 
for products used daily in the workplace or 
at home (such as cosmetics), we believe they 
may reasonably be assumed to represent regu-
lar individual exposure before pregnancy, 
despite the fact that urine collection took 
place in early pregnancy. Changes in work 
environment at the beginning of pregnancy 
are not likely because they are not mandatory 
for occupations such as health care workers 
and beauticians or hairdressers, occupations 
likely to explain most of the occupational GE 
exposure in our cohort (Cordier et al. 2012). 
However we cannot exclude possible changes 
in behavior during pregnancy, in particular, 
changes in the use of cosmetics (i.e, lotions 
used to reduce the occurrence of stretch marks 
although these problems are likely to occur 
later in pregnancy). Despite the widespread 
use and potential toxicity of GEs, no one 
has, to our knowledge, studied their toxico-
kinetic variability, including during pregnancy. 
Accordingly, it is possible that our biomonitor-
ing, based only a single urine sample, did not 
capture total intra individual variability. Urine 
PhAA concentrations were significantly associ-
ated with only one occupational group in our 
study population, hair dressers and beauticians 
(Cordier et al. 2012). Although we did not col-
lect data on personal cosmetic use, we believe 
it is likely to explain most of the exposure to 
EGPhE, because only 12 participants reported 
working as hairdressers and cosmeticians and 
the association between PhAA and TTP per-
sisted after excluding them from the analysis 
(fOR = 0.72; 95% CI: 0.53, 0.98 for the Q4 
concentration of PhAA compared with Q1).
Although we believe that an effect of 
EGPhE or its metabolite PhAA on TTP is 
biologically plausible, we cannot rule out the 
possibility that urine PhAA concentrations 
were acting as a proxy marker of exposure 
to other chemicals, including preservatives 
frequently present in cosmetics, such as 
phthalates or parabens. Among phthalates 
that have been present in cosmetics, di-n-
butyl phthalate (DBP) has been associated 
with a decrease in fertility in the female rat 
(Gray et al. 2006), but this phthalate was 
banned in cosmetics in France in 2004. A 
French survey (ANSM 2012) showed that 
EGPhE and parabens are frequently present 
together in cosmetics. Parabens were not 
measured in the urinary samples in our 
study. Nevertheless, although some parabens 
(methyl, butyl, benzyl, and isobutylparaben) 
have been associated with utero trophic effects 
in mice or rats at high doses, there is no 
current evidence that parabens might impair 
female fertility (Boberg et al. 2010).
Statistical power to detect an effect 
on fecundability was reduced by our study 
design: Because our population was limited 
to pregnant women, it under represented less 
fertile couples and possibly led to the under-
estimation of effects. The short recall time 
(during the first 4 months of pregnancy) com-
pensated in part for the retro spec tive collec-
tion of TTP data (Zielhuis et al. 1992). The 
consistent results of the multiple sensitivity 
analyses we performed, in accordance with 
recommendations for addressing other pos-
sible biases related to this study design (Joffe 
et al. 2005; Weinberg et al. 1994), reduce but 
do not eliminate concerns about the potential 
influences of these biases on our results.
Because parity and miscarriage might 
reflect a certain degree of fertility, we chose in 
advance not to adjust for them. If an associa-
tion existed, they might be seen as exposure 
consequences and then be considered as inter-
mediate factors in the study of the relation 
between exposure and subfertility. 
Conclusion
Among all GEs measured in urine samples 
collected during pregnancy, we found evidence 
of longer TTP in association with PhAA. 
PhAA, which was widely detected in our study 
population, and its main precursor (EGPhE) 
are biologically plausible causes of decreased 
fecundability, but this biomarker may also be 
a surrogate for co-exposures frequently present 
in cosmetics. Finally, given the inherent limi-
tations of retrospective TTP studies, further 
prospective studies on this topic are warranted.
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